Payless Compounders, LLC recalls Semaglutide-Glycine-Cyanocobalamin Injectable
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Semaglutide-Glycine-Cyanocobalamin Injectable
- Company
- Payless Compounders, LLC
- Where it was sold
-
OR
States: Oregon
- Units affected
- 91 vials
- About this recall
- Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR